DK0412466T3 - Fremgangsmåde til fremstilling af en stabil faktor VIII - Google Patents

Fremgangsmåde til fremstilling af en stabil faktor VIII

Info

Publication number
DK0412466T3
DK0412466T3 DK90115005.2T DK90115005T DK0412466T3 DK 0412466 T3 DK0412466 T3 DK 0412466T3 DK 90115005 T DK90115005 T DK 90115005T DK 0412466 T3 DK0412466 T3 DK 0412466T3
Authority
DK
Denmark
Prior art keywords
factor viii
producing
stable factor
stable
adsorptions
Prior art date
Application number
DK90115005.2T
Other languages
Danish (da)
English (en)
Inventor
Gerhardt Kumpe
Klaus Wellner
Norbert Dr Prof Heimburger
Karl-Heinz Wenz
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Application granted granted Critical
Publication of DK0412466T3 publication Critical patent/DK0412466T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK90115005.2T 1989-08-07 1990-08-04 Fremgangsmåde til fremstilling af en stabil faktor VIII DK0412466T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3926034A DE3926034C3 (de) 1989-08-07 1989-08-07 Verfahren zur Herstellung eines stabilen Faktors VIII

Publications (1)

Publication Number Publication Date
DK0412466T3 true DK0412466T3 (da) 1994-05-24

Family

ID=6386638

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90115005.2T DK0412466T3 (da) 1989-08-07 1990-08-04 Fremgangsmåde til fremstilling af en stabil faktor VIII

Country Status (12)

Country Link
US (1) US5424401A (ja)
EP (1) EP0412466B1 (ja)
JP (1) JP3180957B2 (ja)
KR (1) KR0174262B1 (ja)
AT (1) ATE101041T1 (ja)
AU (1) AU635298B2 (ja)
CA (1) CA2022650C (ja)
DE (2) DE3926034C3 (ja)
DK (1) DK0412466T3 (ja)
ES (1) ES2062222T3 (ja)
IE (1) IE63919B1 (ja)
PT (1) PT94917B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4111393A1 (de) * 1991-04-09 1992-10-15 Behringwerke Ag Stabilisierte faktor viii-praeparationen
SE9403915D0 (sv) * 1994-11-14 1994-11-14 Annelie Almstedt Process A
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
EP0885394B1 (de) * 1996-03-08 2000-08-16 Octapharma AG Verfahren zur eignungsprüfung von faktor viii-haltigen proteinfraktionen
DK2193809T3 (en) 1999-02-22 2015-05-26 Univ Connecticut The albumin-free Factor VIII formulation
MX339060B (es) 2008-11-07 2016-05-09 Baxter Int Formulaciones del factor viii.
WO2015107222A1 (en) * 2014-01-20 2015-07-23 Octapharma Ag A process for manufacturing factor viii having an improved ratio of fviii:c/fviii:ag

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE713764A (ja) * 1967-05-01 1968-09-16 Baxter Travenol Lab
JPS52125609A (en) * 1976-04-09 1977-10-21 Green Cross Corp:The Purification of agglutination factor viii
CA1054052A (en) * 1976-08-14 1979-05-08 Edward Shanbrom Simplified method for preparation of high yield, high purity factor viii concentrate
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
US4305870A (en) * 1979-01-31 1981-12-15 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Intravenous plasma derivatives and their production
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
SE448945B (sv) * 1979-12-20 1987-03-30 Blombaeck E G B Forfarande for rening och /eller koncentrering av faktor viii-komplexet
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4495175A (en) * 1982-08-05 1985-01-22 University Of Rochester Preparation of highly purified human antihemophilic factor
DE3432083A1 (de) * 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
AU6487286A (en) * 1985-11-08 1987-05-14 Baxter Travenol Laboratories Inc. Antihemophilic factor by cold precipitation
JPS63108000A (ja) * 1986-05-15 1988-05-12 Green Cross Corp:The 第８因子の精製方法
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
FR2681867B1 (fr) * 1991-09-26 1993-12-31 Pasteur Merieux Serums Vaccins Procede de purification du facteur viii et preparations obtenues.

Also Published As

Publication number Publication date
IE63919B1 (en) 1995-06-14
DE3926034A1 (de) 1991-02-14
CA2022650C (en) 2001-06-05
PT94917B (pt) 1997-05-28
EP0412466A3 (en) 1991-09-18
JP3180957B2 (ja) 2001-07-03
EP0412466B1 (de) 1994-02-02
DE59004488D1 (de) 1994-03-17
JPH03148294A (ja) 1991-06-25
KR910004208A (ko) 1991-03-28
IE902817A1 (en) 1991-02-27
PT94917A (pt) 1991-04-18
KR0174262B1 (ko) 1999-02-18
DE3926034C2 (ja) 1992-06-04
US5424401A (en) 1995-06-13
AU635298B2 (en) 1993-03-18
ATE101041T1 (de) 1994-02-15
DE3926034C3 (de) 1996-11-21
CA2022650A1 (en) 1991-02-08
EP0412466A2 (de) 1991-02-13
AU6015090A (en) 1991-02-07
ES2062222T3 (es) 1994-12-16

Similar Documents

Publication Publication Date Title
CA2009946A1 (en) Pasteurized, purified von willebrand factor concentrate and a process for the preparation thereof
NZ217185A (en) Alleviating cytopathic effects of htlv-iii virus on cells; pharmaceutical composition
PT79187A (en) Process for preparing 1-heteroaryl-4-<(2,5-pyrrolidinedion-1-yl)-alkyl>-piperazine derivatives and of pharmaceutical compositions containing the same
HUT52070A (en) Herbicide compositions containing pyrimidinyl-benzoic acid derivatives as active components, and process for producing the active components
DE58909847D1 (de) Verfahren zur Herstellung von Diorganodialkoxysilanen
DK0412466T3 (da) Fremgangsmåde til fremstilling af en stabil faktor VIII
NZ218546A (en) 2-imidazolin-2-yl fusedheteropyridine compounds and use as herbicides
HUT47793A (en) Herbicide compositions containing 2,6-substituted-pyridine-carboxylic acid derivatives as active components and process for producing the active components
CA2023405A1 (en) Process for purifying n-phosphonomethylglycine
PT84048A (fr) Procede de preparation de nouvelles phenyl-naphthyridines comportant un substituant methyle en position-3 et des medicaments qui en contiennent
ZA936473B (en) Process for preparing distyrylbiphenyl compounds.
HUT44011A (en) Herbicide compositions containing n-substituted-3,4,5,6-tetrahydro-phtalimide derivatives as active components and process for producing the active components
EP0603671A3 (de) Verfahren zur Reaktivierung von gereinigten Membranproteinen.
CA2096888A1 (en) Process for the inactivation of viruses in preparations of proteins
HUT47792A (en) Herbicide compositions containing 2,6-substituted-pyridine-carboxylic acid derivatives as active components and process for producing the active components
AU1630288A (en) Substituted compounds, processes for their preparation and uses thereof
IL91986A0 (en) 2-azabicyclo(2.2.1)hept-5-ene-2-acetic acid,derivatives thereof and related compounds,process for the preparation of said compounds and the use of said compounds for the manufacture of n-phosphonomethylglycine
AU4268889A (en) New 2-carbonyl substituted n, n'-di-(trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them
ATE88188T1 (de) Verfahren zur herstellung von antihaemophilem faktor (faktor viii), der eine hohe reinheit aufweist.
SG52396A1 (en) Process for preparing purified 2,6-naphtalenedicorboxylic acid
CS387591A3 (en) Asymmetric hydrogenation
PT85359A (en) Process for preparing non-flamable air freshner compositions containing dimethyl methylphosphonate as co-solvent
EP0129904A3 (en) Process for the preparation of cis-2,6-dimethyl morpholine
GR3030042T3 (en) Enantiomeric pure cis-2-oxa-5,8-diazabicyclo (4.3.0)nonanes and process for their preparation
ZA93477B (en) Alpha-Aryl-Alpha-hydroxy-Beta-imidazolinyl-propionamides